Cannabidiol Market to grow at a CAGR of 14.85% during 2026 to 2035; Driven by Rising Demand for Cannabidiol-Based Products and Expanding Applications in Healthcare and Wellness

CBD Market Highlights

The Cannabidiol (CBD) Market closed 2025 at USD 10.72 billion and opens the forecast window at USD 12.41 billion in 2026, tracking toward USD 43.15 billion by 2035 at a 14.85% CAGR.

Cannabidiol (CBD), a non-intoxicating compound derived from the cannabis plant, has gained significant traction globally owing to its wide-ranging therapeutic properties and increasing legalization across regions. Unlike THC, CBD does not produce psychoactive effects, making it a safe and effective choice for medical and wellness applications. 

Rising cases of chronic conditions such as anxiety, depression, diabetes, and inflammation have spurred the demand for CBD-based products. Additionally, increasing investment in research and development (R&D), growing awareness of natural and organic treatments, and evolving consumer preferences are key drivers propelling market growth. 

However, stringent government regulations and potential side effects of cannabis-based products are expected to challenge market expansion during the forecast period. 

MRFR recognizes the following companies as the key players in the Global CBD Market— Aphria Inc., Folium Biosciences, Freedom Leaf Inc., Green Roads of Florida LLC, CBD Health Solutions LLC, ENDOCA, Isodiol International Inc., CV Sciences Inc., Medical Marijuana Inc., Canopy Growth Corporation, and Elixinol Global Limited. 

Segment Analysis

The Global CBD Market has been segmented based on Form, Route of Administration, Product Type, Application, Fusion Type, Extract Type, Distribution Channel, and Region. 

• Based on Form Type, the market is segmented into Solid and Liquid. The Liquid segment dominates due to its application in tinctures, oils, and beverages.


• Based on Route of Administration, the market includes Tinctures, Capsules, Inhalation (Smoke or Vapor), and Aerosol Sprays. Among these, tinctures lead due to dosage flexibility and rapid absorption.


• Based on Product Type, the market is divided into Food Grade and Therapeutic Grade. Therapeutic Grade CBD holds the largest share due to its use in healthcare and pharmaceutical products.


• Based on Application, the market is categorized into Neurodegenerative Disorders, Fibromyalgia, Diabetes, Protein Bars, and Energy Drinks. The increasing use of CBD in treating neurological and metabolic disorders drives this segment.


• Based on Fusion Type, the market includes Healthcare and Food & Beverages. Healthcare dominates due to the growing use of CBD in medical formulations.


• Based on Extract Type, segmentation includes Full Spectrum, Broad Spectrum, and Isolate. Full Spectrum CBD is witnessing high demand due to its synergistic therapeutic benefits.


• Based on Distribution Channel the market includes Online Platforms, Retail Stores, and Pharmacies. The Online segment is growing rapidly with the expansion of e-commerce channels.

Region Analysis

By Region, the CBD market is segmented into North America, Europe, Asia Pacific, South America, and the Middle East & Africa. 

• Americas: The Americas hold the largest market share, driven by increasing legalization of cannabis-based products and growing demand for CBD-infused edibles, beverages, and health supplements. The U.S. Food and Drug Administration’s (FDA) positive stance toward CBD regulation is expected to further boost adoption in the coming years.


• Europe: Europe is the second-largest market, supported by favorable regulations, growing awareness of CBD’s therapeutic benefits, and strong product development in countries such as the UK, Germany, and Switzerland.


• Asia Pacific: The Asia Pacific region is the third-largest and fastest-growing market, driven by countries like China, India, and Japan. China’s approval of hemp cultivation for CBD extraction has opened new avenues for industrial expansion, though restrictions on cannabis-infused products remain in some regions.


• Middle East & Africa: Growth in this region remains moderate due to strict regulations and limited acceptance of cannabis-based products. However, ongoing reforms and growing awareness of CBD’s medical benefits may create opportunities in the near future.

Key Findings of the Study

• Pharmaceuticals held 38.1% of the cannabidiol (CBD) Market share in 2025, underpinned by three approved cannabinoid molecules.


• Pet care is the standout growth pocket at a 29.1% CAGR, the fastest of any end-use category.


• Wellness and personal use contributed roughly USD 3.58 billion in base-year revenue.


• North America generated 43.4% of 2025 Cannabidiol (CBD) Market revenue


• Asia-Pacific is forecast to expand at an 18.4% CAGR through 2035


• Europe's contribution reached approximately USD 2.98 billion in 2025